Chai‐Ni Chang

1.2k total citations
7 papers, 525 citations indexed

About

Chai‐Ni Chang is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Chai‐Ni Chang has authored 7 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Pathology and Forensic Medicine and 3 papers in Immunology. Recurrent topics in Chai‐Ni Chang's work include Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Chai‐Ni Chang is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Chai‐Ni Chang collaborates with scholars based in United States, United Kingdom and Poland. Chai‐Ni Chang's co-authors include Julie Yates, Donald H. Horstman, Tracy Fischer, Tushar Shah, Donald A. Mahler, Ira Gupta, Sebastian Grosicki, Astrid McKeown, Ann Janssens and Steen Lisby and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and American Journal of Hematology.

In The Last Decade

Chai‐Ni Chang

7 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chai‐Ni Chang United States 6 397 299 130 130 55 7 525
S. Arthanari United Kingdom 3 340 0.9× 213 0.7× 13 0.1× 99 0.8× 19 0.3× 8 411
Martin Plaisance Canada 4 366 0.9× 123 0.4× 149 1.1× 19 0.1× 47 0.9× 7 408
P. Jane McDowell United Kingdom 8 174 0.4× 213 0.7× 29 0.2× 16 0.1× 46 0.8× 16 309
C Day United Kingdom 6 101 0.3× 44 0.1× 50 0.4× 31 0.2× 30 0.5× 13 260
Elena Treppo Italy 10 107 0.3× 39 0.1× 45 0.3× 23 0.2× 26 0.5× 28 205
Ana Águeda Portugal 6 149 0.4× 20 0.1× 37 0.3× 19 0.1× 40 0.7× 18 216
G. Giammarresi Italy 6 133 0.3× 41 0.1× 22 0.2× 14 0.1× 132 2.4× 6 396
Monica Calderón-Goercke Spain 8 210 0.5× 35 0.1× 71 0.5× 33 0.3× 11 0.2× 19 234
R Loire France 7 252 0.6× 35 0.1× 21 0.2× 13 0.1× 14 0.3× 38 311
Outi Jauhola Finland 7 313 0.8× 21 0.1× 14 0.1× 18 0.1× 50 0.9× 8 351

Countries citing papers authored by Chai‐Ni Chang

Since Specialization
Citations

This map shows the geographic impact of Chai‐Ni Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chai‐Ni Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chai‐Ni Chang more than expected).

Fields of papers citing papers by Chai‐Ni Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chai‐Ni Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chai‐Ni Chang. The network helps show where Chai‐Ni Chang may publish in the future.

Co-authorship network of co-authors of Chai‐Ni Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Chai‐Ni Chang. A scholar is included among the top collaborators of Chai‐Ni Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chai‐Ni Chang. Chai‐Ni Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Robak, Tadeusz, Krzysztof Warzocha, Govind Babu, et al.. (2016). Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial. Leukemia & lymphoma. 58(5). 1084–1093. 39 indexed citations
2.
Flinn, Ian W., Panayiotis Panayiotidis, Boris V. Afanasyev, et al.. (2016). A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL. American Journal of Hematology. 91(9). 900–906. 17 indexed citations
3.
4.
5.
6.
7.
Mahler, Donald A., Donald H. Horstman, Chai‐Ni Chang, et al.. (2002). Effectiveness of Fluticasone Propionate and Salmeterol Combination Delivered via the Diskus Device in the Treatment of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 166(8). 1084–1091. 383 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Arthanari Breakdown of academic impact, for papers by Martin Plaisance Breakdown of academic impact, for papers by P. Jane McDowell Breakdown of academic impact, for papers by C Day Breakdown of academic impact, for papers by Elena Treppo Breakdown of academic impact, for papers by Ana Águeda Breakdown of academic impact, for papers by G. Giammarresi Breakdown of academic impact, for papers by Monica Calderón-Goercke Breakdown of academic impact, for papers by R Loire Breakdown of academic impact, for papers by Outi Jauhola
Rankless by CCL
2026